metabolic research comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-06-26. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from C-terminal region of human growth hormone |
| Approximate molecular mass | About 1.8 kDa | Varies with sequence length and counterions |
| Confirmed receptor target | None established | No confirmed growth hormone receptor agonism |
| Reported in vitro activity | Lipolysis stimulation and lipogenesis inhibition | Observed mainly in adipocyte models; human relevance uncertain |
| Regulatory status | Not approved as a drug in major markets | May be treated differently across jurisdictions; not a recognized dietary ingredient in some countries |
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
As a chemist he is known best for his work on organic synthesis, including discovery of the aldol reaction Hans-Joachim Born (1909–1987), German radiochemist who participated in the Soviet nuclear weapons programme Carl Bosch (1872–1940), German chemist, pioneer in the field of high-pressure industrial chemistry. Nobel Prize in Chemistry 1931 Octave Leopold Boudouard (1872–1923), French chemist who discovered the Boudouard reaction: combination of carbon and carbon dioxide to form carbon monoxide at high temperatures Jean-Baptiste Boussingault (1802–1887), French chemist with work in agricultural science, petroleum science and metallurgy
In February 2025, Mahathir's official Facebook account confirmed that his X account (@chedetofficial) had been hacked, resulting in a post promoting cryptocurrency, and efforts were underway to recover it. In April 2025, following the Putra Heights pipeline fire in Subang Jaya, Mahathir visited the Incident Control Post and urged the public not to make premature accusations before the investigation was completed. Shortly thereafter, he also attended the state funeral of former prime minister Abdullah Ahmad Badawi. In an interview in May 2025, he criticised Donald Trump's tariff policies and described him as "living in an old world" over his foreign policy. On 10 July 2025, Mahathir reached the age of 100, making him one of the few world leaders to become a centenarian. The occasion was widely reported by local and international media, and Prime Minister Anwar Ibrahim, among others, extended birthday wishes. Despite his age, Mahathir remained intellectually active, continuing to write, speak, and share his views through various platforms. Three days later, he was admitted to the National Heart Institute (IJN) for observation due to fatigue, following his participation in a cycling event and a gathering to celebrate his and his wife's birthdays. He was discharged the same day. On 26 July 2025, Mahathir participated in the Turun Anwar rally at Dataran Merdeka, joining several opposition leaders in calling for Prime Minister Anwar Ibrahim's resignation.
=== Heavy metals === Heavy metals are toxic for living organisms. High soil concentrations of heavy metals such as zinc, copper, cadmium, lead, nickel, and chromium affect basic metabolic processes and can lead to cell damage and death. Some ectomycorrhizal fungi are tolerant to heavy metals, with many species having the ability to colonize contaminated soils. There are also cases of populations locally adapted to tolerate harsh chemical environments. Fungi exhibit detoxification mechanisms to reduce heavy metal concentrations in their cells. These mechanisms include reducing heavy metal uptake, sequestering and storing heavy metals within the cell, and excretion. Heavy metal uptake can be reduced by sorption and metabolic inactivation at the cell wall and apoplast level. Ectomycorrhizal fungi also have the ability to bind considerable amounts of heavy metals. Once inside the cell, heavy metals can be immobilized in organo-metal complexes, made soluble, transformed into metallothioneins, involved in metal sequestration and/or stored in vacuoles in chemically inactive forms. Antioxidant detoxification systems may also be in place, reducing the production of free radicals and protecting the fungal cell. Fungi can export metals from the cytoplasm to the apoplast, a mechanism that also occurs in plants. Ectomycorrhizal fungi can also concentrate heavy metals in their fruiting bodies. Genetic differences between populations growing in toxic versus non-toxic habitats have rarely been reported, indicating that metal tolerance is widespread.
Sources: en.wikipedia.org
Once approved, the political reform referendum was convened for December 15. The government did not give any opportunity to the opposition to present its position ─ abstention ─ in the media it controlled, especially in the most influential one, the television ─ nor even in the radio ─ and deployed a formidable campaign in favor of the YES, so the result of the referendum did not bring any surprise: there was a high turnout, except in the Basque Country, and the YES won with 94.2% of the votes, while the NO, defended by the búnker, only got 2.6%. The "political reform", and implicitly the monarchy and its government, were thus legitimized by the popular vote. From that moment on, the opposition's demand for the formation of a government of "broad democratic consensus" no longer made sense. It would be the Suárez government that would assume the task that the opposition had assigned to that government: to call general elections. During the last week of January 1977 the most delicate moment of the transition before the elections took place, as the Francoists in the búnker set out to stop the process of change by creating a climate of panic that would justify the intervention of the Army. The first provocation came in Madrid's Gran Vía, when a student, Arturo Ruiz, who was taking part in a pro-amnesty demonstration was killed by thugs of the extreme right-wing group Fuerza Nueva ─ in the demonstration protesting the crime a demonstrator, María Luz Nájera, was killed by a police smoke canister.
A medical test is a medical procedure performed to detect, diagnose, or monitor diseases, disease processes, susceptibility, or to determine a course of treatment. The tests are classified by speciality field, conveying in which ward of a hospital or by which specialist doctor these tests are usually performed. The ICD-10-CM is generally the most widely used standard by insurance companies and hospitals who have to communicate with one another, for giving an overview of medical tests and procedures. It has over 70,000 codes. This list is not exhaustive but might be useful as a guide, even though it is not yet categorized consistently and only partly sortable.
== In the news == On January 5th, 2026, Nestlé issued a global recall of some batches of infant formula, due to the presence of cereulide. The cereulide was found in a Nestlé production facility in Nunspeet the Netherlands. On January 24th 2026, Danone also recalled a single batch of infant formula. The contaminated ingredient was arachidonic acid oil.
=== Social anxiety disorder === SSRIs show some evidence of effectiveness for social anxiety disorder, including reducing relapse and disability, but the overall quality of evidence is low to moderate and tolerability is slightly lower than placebo.
Sources: en.wikipedia.org
== Pharmacokinetics == Endogenous GLP-1 has a plasma half-life of 1.5–2 minutes due to degradation by the ubiquitous enzymes, dipeptidyl peptidase-4 (DPP4) and neutral endopeptidases (NEP). The half-life after intramuscular injection is approximately half an hour, so even administered this way, it has limited use as a therapeutic agent. The metabolically active forms of GLP-1 are the endogenous GLP-1-(7-36)NH2 and the more rare GLP-1-(7-37). The prolonged action of liraglutide is achieved by attaching a fatty acid molecule at one position of the GLP-1-(7-37) molecule, enabling it to both self-associate and bind to albumin within the subcutaneous tissue and bloodstream. The active GLP-1 is then released from albumin at a slow, consistent rate. Albumin binding also results in slower degradation and reduced renal elimination compared to that of GLP-1-(7-37).
=== Category:EC 1.12 (act on hydrogen as a donor) === Category:EC 1.12.1 (with NAD+ or NADP+ as acceptor) Category:EC 1.12.2 (with a cytochrome as acceptor) Category:EC 1.12.5 (with a quinone or similar compound as acceptor) Category:EC 1.12.7 (with an iron–sulfur protein as acceptor) Category:EC 1.12.98 (with other known acceptors) Category:EC 1.12.99 (with other acceptors)
Transmucosal (diffusion through a mucous membrane), e.g. insufflation (snorting) of cocaine, sublingual, i.e. under the tongue, sublabial, i.e. between the lips and gingiva, and oral spray or vaginal suppository for nitroglycerine.
Sources: en.wikipedia.org
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.
It is not approved as a prescription drug in the United States or the European Union for any indication. Regulatory status can differ by country, and it is often sold as a research chemical or in unapproved products. Such products are not equivalent to an approved medicine.
In the studies reported so far, AOD9604 does not appear to act through the growth hormone receptor and has not shown the typical IGF-1 increase caused by full-length hGH. Human data are limited, so this remains an area of uncertainty. It should not be assumed to have the same effects as hGH.
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.